Literature DB >> 20833989

Hypoadiponectinemia is strongly associated with metabolic syndrome in Korean type 2 diabetes patients.

Han Kyoung Ryu1, So Young Yu, Jong Suk Park, Young Ju Choi, Kap Bum Huh, Ji Eun Park, Ji-Yun Hwang, Wha Young Kim.   

Abstract

OBJECTIVE: To evaluate the relationship between serum adiponectin level, dietary intake, and metabolic syndrome (MetS) in type 2 diabetes mellitus (DM) patients, and to identify factors associated with serum adiponectin level.
METHODS: A cross-sectional study was performed using 789 type 2 DM patients (406 men and 383 women) 40-80 years old. Subjects were classified into 3 groups on the basis of serum adiponectin level. General characteristics and anthropometric, hematologic, and dietary data were obtained for each subject.
RESULTS: The prevalence of hypoadiponectinemia (<4.0 µg/mL) was 57.4% in men and 32.4% in women. Serum adiponectin level was negatively correlated with body mass index (BMI), waist circumference, body fat percentage, and serum concentrations of insulin and triglyceride, and was positively correlated with high-density lipoprotein (HDL)-cholesterol level. Even though the direct association of nutrient intake with serum adiponectin concentration was not strong, various contributing factors for hypoadiponectinemia were strongly correlated with micronutrient intake, such as calcium, iron, and niacin. Both sexes in the group with the lowest adiponectin concentration had a higher prevalence of MetS and MetS components than corresponding sexes in the group with the highest adiponectin concentration.
CONCLUSIONS: Our findings show that hypoadiponectinemia is strongly associated with MetS in type 2 DM patients. Dietary intake may be indirectly associated with adiponectin levels through factors such as BMI, waist circumference, insulin, homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride, HDL-cholesterol, and blood pressure. Therefore, our results suggest that manipulation of the level of adiponectin may prevent MetS and reduce the risk of cardiovascular disease in type 2 DM patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833989     DOI: 10.1080/07315724.2010.10719831

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  5 in total

1.  Accelerated aging as evidenced by increased telomere shortening and mitochondrial DNA depletion in patients with type 2 diabetes.

Authors:  Finny Monickaraj; Sankaramoorthy Aravind; Kuppan Gokulakrishnan; Chandrakumar Sathishkumar; Paramasivam Prabu; Durai Prabu; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Mol Cell Biochem       Date:  2012-03-13       Impact factor: 3.396

2.  Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.

Authors:  Hannah Gardener; Milita Crisby; Charlotte Sjoberg; Barry Hudson; Ronald Goldberg; Armando J Mendez; Clinton B Wright; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco
Journal:  Metab Syndr Relat Disord       Date:  2012-11-05       Impact factor: 1.894

3.  Association of genetic variants in the adiponectin gene with metabolic syndrome: a case-control study and a systematic meta-analysis in the Chinese population.

Authors:  Meng Gao; Daxia Ding; Jinghua Huang; Yali Qu; Yu Wang; Qingyang Huang
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

4.  Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome.

Authors:  M K Garg; M K Dutta; Namita Mahalle
Journal:  Indian J Endocrinol Metab       Date:  2012-01

5.  High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects.

Authors:  Virgínia Genelhu de Abreu; Cyro José de Moraes Martins; Patricia Aguiar Cardoso de Oliveira; Emilio Antonio Francischetti
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.